digital therapeutics

By Dave Muoio June 20, 2018
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension. Accompanying these are a set of new features for the enterprise and health plan platform focused on medication adherence and remote monitoring, all of which comprise what a representative from the company described as “the...
By Dave Muoio June 14, 2018
The past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD). The studies, published in npj Digital Medicine, the Journal of Affective Disorders, and presented at the Society of Biological Psychiatry Annual Scientific Convention in New York, showed the therapeutic to reduce symptoms, pair well with...
By Dave Muoio June 8, 2018
Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception. This week Boston was host to the Biotechnology Innovation Organization’s annual conference, a multi-day gathering of leading pharma and biotech leaders from across the globe. While, admittedly, digital health wasn’t always the primary interest of many attendees and speakers, it was...
By Laura Lovett June 7, 2018
A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston. The way the pharma industry looks at medication is evolving and may be including new tech-focused treatments, such as digital therapeutics. “If you think about the trajectory of medicine what is a drug these days: is it a pill, is it an injection, is it infusion, is it gene therapy? We’ve...
By Dave Muoio June 6, 2018
Stakeholders across healthcare are beginning to weigh the benefits and challenges digital therapeutics could bring to their businesses, and pharma is no exception. During an afternoon roundtable session held Wednesday at BIO 2018 in Boston, a panel of digital medicine and pharmaceutical representatives discussed the impact that these novel medicines has had, and could have, on drugmakers,...
By Dave Muoio May 30, 2018
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma. Existing investors Safeguard Scientifics, Social Capital, Hikma Ventures, 3M Ventures, and SR One comprised the other half of the round. According to a release, the new funding will be invested into the company’s digital...
By Jonah Comstock May 22, 2018
San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming the control group in every outcome measure, though there was some loss of engagement among the study group. “It was really strong results,” CEO Daniel Perez told MobiHealthNews. “It was a trial that...
By Dave Muoio May 18, 2018
Although it hasn’t yet established its place as a mainstream treatment modality, virtual reality has grown from an interesting diversion into a frequent topic of conversation within digital health. As researchers continue to dig their teeth into the immersive technology, it’s becoming clear that this new tool, often associated with video gaming and entertainment, could play a role in addressing...
By Dave Muoio May 9, 2018
This morning, Boston-based Akili Interactive Labs announced the closure of a $55 million Series C funding round. The investment was led by Temasek, with participation from Baillie Gifford, Amgen Ventures, M Ventures, JAZZ Venture Partners, Canepa Advanced Healthcare Fund, and Brooklands Capital Strategies. According to the company, this new funding will be used to support development, regulatory...
By Dave Muoio March 21, 2018
A small, 6-week retrospective study published in JMIR mHealth and uHealth found that a behavior health-focused videogame developed by digital health company Litesprite improved self-reported measures of depression, anxiety, and confidence in coping skills. “What was unique and remarkable about the study is the participants using Sinasprite were completely self-directed and received no clinician...